Company intelligence / Profile preview

XEMA

Lappeenranta, South Karelia, Finlandxema.com.ua ↗

Ownership: Private
Employees: ~32
Development stage: Other

Overview

XEMA is a long-established manufacturer of ELISA and rapid test kits for clinical diagnostics, veterinary testing, food quality control, environmental monitoring, and forensic applications. The company produces its own monoclonal antibodies and recombinant proteins used as key reagents in these tests. Their products are distributed globally to other diagnostic companies and research organizations[1][4].

Therapeutic areas: Infectious Diseases
Modalities: Monoclonal antibodyRecombinant proteinSmall molecule (for diagnostic reagents)
Industry: Protein Biomarker Diagnostics

Partnerships

Hytest OyFitzgerald Industries InternationalZAO “Vector-Best”NPO “DS”Granum CompanyGlobe Diagnostic Srl.Orgenics

Beyond the preview

Go deeper on XEMA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on XEMA.

Explore the full profile